Sign in
Enrolling by invitationNo phase

Multimodal Fetal and Placental Imaging and Biomarkers of Clinical Outcomes in Opioid Use Disorder

Key facts

Who runs it
Senthil Sadhasivam
Where
Indianapolis and Pittsburgh, United StatesSee the 2 sites
Trial code
Status
Enrolling by invitation
People taking part
250 people, planned
Started
13 Feb 2024
Expected to end
1 Dec 2029
Type of study
Observational, 2 groups
Treatments tested
  • Buprenorphine or Methadone Treatment
  • Fetal and Placental MRI
  • Child Developmental Assessment
  • Questionnaires
  • Blood and Placental Samples
Record updated
14 July 2026

Who can take part

Age
18 years to 100 years
Sex
Women only
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Age >18 years
  • Currently taking buprenorphine or methadone for OUD and are enrolled in a prenatal opioid maintenance program
  • Singleton Pregnancy
  • Planned delivery at Indiana University or University of Pittsburgh study sites

Who cannot take part

  • Serious maternal medical illness as deemed by study physician investigators that would make it challenging to comply with study procedures
  • HIV or AIDS; Infants with prenatal opioid exposure:; Inclusion:
  • Born to mother enrolled in Opioid Use Disorder arm of study; Exclusion:; Major congenital anomalies or genetic syndromes affecting neurodevelopment; Control Pregnant Women:; Inclusion:
  • Serious maternal medical illness as deemed by study physician investigators that would make it challenging to comply with study procedures
  • HIV or AIDS
  • Any history of opioid misuse before or during pregnancy-per self-report and clinical notes; Control infants:; Inclusion:; Born to control pregnant mother enrolled in study; Exclusion:; Any major congenital anomalies, genetic abnormalities, neurologic abnormalities, syndromes, or chronic medical conditions affecting neurodevelopment
  • Women >18 Years of age
  • Known or suspected major fetal/ neonatal congenital abnormalities
  • Prenatal buprenorphine or methadone exposure
  • Healthy singleton pregnancy
  • Planned delivery at Indiana University or University of Pittsburgh study sites; Exclusion:
  • Known or suspected major fetal congenital abnormalities

Other criteria

  • Pregnant women with opioid use disorder

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

Where in United States

  • Riley Hospital for ChildrenIndianapolis, United StatesEnrolling by invitation
  • University of PittsburghPittsburgh, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The goal of this observational study is to learn about the long term effects of prenatal opioid exposure. The main objectives are:

Read full original descriptionShow less

* Long term goal: to improve the safety and efficacy of maternal Opioid Use Disorder (OUD) and eliminate neonatal opioid withdrawal syndrome (NOWS) and poor childhood neurodevelopment. * To characterize prenatal opioid exposure (POE) related placental and fetal brain structural and functional disruptions using longitudinal placenta-fetal brain magnetic resonance imaging (MRI) and determine proteomic, genomic, and epigenetic signatures of NOWS and poor infant neurodevelopment.

In this study participants will:

* Receive two placental-fetal MRIs, one during second trimester and one in third trimester. * Answer surveys relating to their medical and social history. * Have blood drawn during pregnancy and delivery. * Child development follow up: answer surveys on their child's development milestones and at one year of life they will undergo a development assessment.

The 2 groups in the trial

  • Pregnant Mothers with Opioid Use Disorder

    150 pregnant mothers with opioid use disorder who are on buprenorphine or methadone treatment

    Treatment: Buprenorphine or Methadone Treatment, Fetal and Placental MRI, Child Developmental Assessment, Questionnaires, and Blood and Placental Samples

  • Pregnant Mothers

    100 pregnant mother who to not have a history of opioid use disorder

    Treatment: Fetal and Placental MRI, Child Developmental Assessment, Questionnaires, and Blood and Placental Samples

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT06415994, who can take part
Record updated
14 July 2026